SHANGHAI OUYI BIOMEDICAL TECHNOLOGY
Shanghai Ouyi Biomedical Technology Co., Ltd., established in 2009, is a high-tech enterprise of multi-omics testing services with "specialization, specialization and new". It has built a multi-omics testing platform covering nucleic acid, protein, and metabolism. Big data analysis platform combined with multi-omics. For pharmaceutical, food and daily chemical companies; life sciences, medicine and clinical research fields, provide drug target discovery, pharmacological efficacy and safety evaluation, disease molecular marker screening, pathogenic bacteria and drug resistance traceability, life development research and Multi-level and multi-omics testing services and solutions for disease occurrence and development research.
SHANGHAI OUYI BIOMEDICAL TECHNOLOGY
Industry:
Biotechnology Health Diagnostics Life Science Medical
Founded:
2009-03-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.oebiotech.com
Total Employee:
101+
Status:
Active
Contact:
+86 400-808-5350
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Domain Not Resolving Apache Mobile Non Scaleable Content Nginx Apple Mobile Web App Capable
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
BGI Group
BGI Group is one of the world’s largest DNA sequencing service providers.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
SpyBiotech
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Current Employees Featured
Founder
Investors List
Orient Securities Capital Investment
Orient Securities Capital Investment investment in Series A - Shanghai Ouyi Biomedical Technology
Sinopharm Capital
Sinopharm Capital investment in Series A - Shanghai Ouyi Biomedical Technology
Official Site Inspections
http://www.oebiotech.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
Unable to get host informations!!!
